A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome

Abstract Background Preclinical studies and anecdotal case reports support the potential therapeutic benefit of low-dose oral ketamine as a treatment of clinical symptoms in Rett syndrome (RTT); however, no controlled studies have been conducted in RTT to evaluate safety, tolerability and efficacy....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Kathleen Campbell, Jeffrey L. Neul, David N. Lieberman, Elizabeth Berry-Kravis, Tim A. Benke, Cary Fu, Alan Percy, Bernhard Suter, David Morris, Randall L. Carpenter, Eric D. Marsh, Jana von Hehn
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-01-01
Σειρά:	Journal of Neurodevelopmental Disorders
Θέματα:	Rett syndrome Ketamine Clinical trial Electroencephalography
Διαθέσιμο Online:	https://doi.org/10.1186/s11689-025-09591-y
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!